Anna Azvolinsky, PhD

Anna Azvolinsky, PhD

Freelance science writer and frequent Cancer Network and OncoTherapy Network contributor.

Follow Her on Twitter

Posts by Author

Men with high midlife cardiorespiratory fitness have a lower incidence of lung and colorectal cancer; however, this association was not seen for prostate cancer.

A combination of biomarkers has shown promise as a surrogate for survival in clinical trials of metastatic castration-resistant prostate cancer.

Women who received cognitive behavioral stress management after surgery for early breast cancer reported better quality of life and lower symptoms of depression.

The FDA requires a risk label on GnRH agonists that indicates the increased risk of cardiovascular disease and diabetes in prostate cancer patients.

While pathologists usually agree on healthy and malignant breast tissue from biopsy slides, there is less agreement on samples that fall somewhere in the middle.

Women with a first-degree relative diagnosed with prostate cancer may be at increased risk for developing breast cancer, according to a new study.

In a phase I trial, DT2219, the novel bispecific ligand-directed toxin, has shown activity against relapsed and refractory B-cell lymphoma and leukemia.

A reduction in testosterone levels in the first year of ADT correlates with improved survival in prostate cancer patients being treated for biochemical failure.

In a large study, it was found that those who ate a vegetarian diet had a lower risk of colorectal cancer compared with their non-vegetarian counterparts.

Researchers have shown that reprogramming T cells to target glioblastoma in mice resulted in control of these tumors.


By clicking Accept, you agree to become a member of the UBM Medica Community.